Interferon-gamma release assay for screening of tuberculosis infection in children [PDF]
Background Interferon-gamma release assay (IGRA) is the main tool for the diagnosis of latent tuberculosis (TB) infection (LTBI). However, the indeterminate results were more frequent in children, and the underlying reasons were largely speculative.
Huiwen Zheng +8 more
doaj +2 more sources
Evaluation of SARS-CoV-2 interferon gamma release assay in BNT162b2 vaccinated healthcare workers [PDF]
To predict protective immunity to SARS-CoV-2, cellular immunity seems to be more sensitive than humoral immunity. Through an Interferon-Gamma (IFN-γ) Release Assay (IGRA), we show that, despite a marked decrease in total antibodies, 94.3% of 123 ...
Angélica Ramos +5 more
doaj +4 more sources
Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis. [PDF]
The diagnosis of tuberculosis remains difficult. This study aimed to assess performance of interferon-gamma release assay (IGRA) in diagnosis of active tuberculosis (ATB) with pulmonary and extrapulmonary involvements, and to determine the diagnostic ...
Yun Feng +9 more
doaj +4 more sources
Spontaneously regressing pulmonary tuberculosis detected by computed tomography in a patient with positive interferon‐gamma release assay [PDF]
Key message We present a case of pulmonary tuberculosis with a positive interferon‐gamma release assay showing spontaneous regression followed by progression of radiological findings.
Yuya Kimura +4 more
doaj +2 more sources
Species-Specific Interferon-Gamma Release Assay for the Diagnosis of Mycobacterium abscessus Complex Infection [PDF]
Mycobacterium abscessus complex (MABC) infection has a devastating impact on the course of cystic fibrosis (CF) and non-CF lung disease. Diagnosis of MABC pulmonary disease is challenging, and current diagnostic approaches lack accuracy, especially in CF.
Mathis Steindor +12 more
doaj +2 more sources
QuantiFERON®-TB gold in-tube performance for diagnosing active tuberculosis in children and adults in a high burden setting. [PDF]
To determine whether QuantiFERON®-TB Gold In-Tube (QFT) can contribute to the diagnosis of active tuberculosis (TB) in children in a high-burden setting and to assess the performance of QFT and tuberculin skin test (TST) in a prospective cohort of TB ...
A Cattamanchi +42 more
core +17 more sources
Objectives: To describe the investigation, follow-up, management, and outcomes in a cohort of chronic kidney disease (CKD) and kidney transplant recipients (KTR) exposed to a case of pulmonary tuberculosis (TB).
Laure Burguet +10 more
doaj +1 more source
Novel approach to activity evaluation for release-active forms of anti-interferon-gamma antibodies based on enzyme-linked immunoassay. [PDF]
Selection of a suitable assay to measure the activity of drug agents based on release-active forms of anti-interferon-gamma antibodies (RA forms of Abs) is an important step forward in the investigation of such agents.
Elena S Gavrilova +5 more
doaj +1 more source
Background: The coronavirus disease 2019 vaccine induces both antibody and T-cell immune responses and has been proven to be effective in preventing coronavirus disease 2019, including its severe disease form, in healthy individuals. However, the details
Ersan Atahan +4 more
doaj +1 more source
Interferon-gamma release assay: use and misuse [PDF]
Interferon-gamma release assays are being increasingly used worldwide for the diagnosis of latent tuberculosis (TB) in patients of all ages, including children [1]. A PubMed search with ‘interferon-gamma release assays’ as keyword revealed a total of 1077 references, up to 100 of which had been released in 2012, including several reviews.
Brouqui, P. +3 more
openaire +2 more sources

